GPT and metabolic dysfunction-associated steatotic liver disease: Therefore, the study confirmed that NAFLD patients with normal ALT are at risk of progressive hepatic disease, and normal ALT cannot be considered a valuable criterion to eliminate the need for liver biopsy [26].